...Fitch Ratings global pharmaceutical team is presenting its Global Pharmaceutical R&D Pipeline report for the third quarter of 2008. This report includes the most current key late-stage research and development (R&D) brand-name pharmaceutical projects, as well as up-to-date financial measures that reflect the risks facing pharmaceutical developers. Recent market introductions of innovative and generic drug products are highlighted as well. The intent of the regula r update is to keep investors informed of the dynamics of brand-name pharmaceutical portfolios of the major U.S. and European participants in the industry. Fitch issues this report on a quarterly basis following earnings reporting. ...

Report Type: Special Report
Company(ies): Bristol-Myers Squibb Company, Eli Lilly & Company, Merck & Company, Inc., AstraZeneca plc, Johnson & Johnson, Wyeth, Sanofi-Aventis S.A., Pfizer Inc., GlaxoSmithKline plc, Abbott Laboratories, Novartis AG, Roche Holding Ltd., Amgen, Inc., Schering-Plough Corporation, Bayer AG
Ticker(s): AMGN , GSK , BMY , PFE , BAY , RO , JNJ , AZN , NOVN , LLY , ABT , SGP , WYE , MRK , SAN
Issuer: Schering-Plough Corporation
Free Sample: Click Here to Download

Enter the keyword(s) which you would like to search for within this document and click "Search"

 

 Fitch Research
Fitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.